AMY WIBLE: Open Payments
NPI 1487176814 · APOPKA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$37 in 2 payments from 2 companies in 2025. Trend: 2023 $108 · 2024 $20 · 2025 $37
Food & beverage: $37
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: Veklury, ZERBAXA.
Industry payments across FL — which companies pay providers there.
